B-hTFR1/hTAU mice

C57BL/6-Tfrctm1(TFRC)Bcgen Mapttm1(MAPT)Bcgen/Bcgen • 113290

B-hTFR1/hTAU mice

Product nameB-hTFR1/hTAU mice
Catalog number113290
Strain nameC57BL/6-Tfrctm1(TFRC)Bcgen Mapttm1(MAPT)Bcgen/Bcgen
Strain backgroundC57BL/6
NCBI gene ID7037, 4137
AliasesCD71, IMD46, T9, TFR, TFR1, TR, TRFR, p90;TAU, MSTD, PPND, DDPAC, MAPTL, MTBT1, MTBT2, tau-40, FTDP-17, PPP1R103, Tau-PHF6
ApplicationThis product is used for pharmacodynamics evaluation of Alzheimer's disease (AD).

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis

Posters

View All

    Publication

      Description
      • TAU is mainly distributed in the central nervous system, most of it exists in the axons of neurons, and a small amount exists in oligodendrocytes. TAU is involved in neurodegenerative diseases, and most prominently in the pathogenesis of Alzheimer disease (AD).
      • TFR1 plays a crucial role in regulating the distribution of iron in the brain, involving multiple biological processes such as cell metabolism, development, myelination, and neurotransmission. Due to the expression of TfR1 in brain endothelial cells, it serves as an ideal target for drug delivery. Various drug delivery strategies targeting TfR1 have been developed to effectively penetrate the blood-brain barrier and promote therapeutic interventions for brain diseases.
      • Gene editing strategy: The exons 2~10 of mouse Mapt gene that encode the full-length protein were replaced by human MAPT exons 2~15 in B-hTFR1/hTAU mice. The 3’UTR region of the mouse gene are replaced by human counterparts. The chimeric MAPT expression is driven by endogenous mouse Mapt promoter, while mouse Mapt gene transcription and translation will be disrupted. The exons 4-19 of mouse Tfr1 gene that encode the extracellular region were replaced by human TFR1 exons 4-19 in B-hTFR1/hTAU mice.
      • Protein expression analysis: TAU were detected in cortex and hippocampus of both wild-type C57BL/6 mice and homozygous B-hTFR1/hTAU mice. Mouse TFR1 was detectable in wild-type mice. Human TFR1 was exclusively detectable in homozygous hTFR1/hTAU mice but not in wild-type mice.
      Targeting strategy

      Gene targeting strategy for B-hTFR1/hTAU mice.The exons 2~10 of mouse Mapt gene that encode the full-length protein were replaced by human MAPT exons 2~15 in B-hTFR1/hTAU mice. The 3’UTR region of the mouse gene are replaced by human counterparts. The chimeric MAPT expression is driven by endogenous mouse Mapt promoter, while mouse Mapt gene transcription and translation will be disrupted. The exons 4-19 of mouse Tfr1 gene that encode the extracellular region were replaced by human TFR1 exons 4-19 in B-hTFR1/hTAU mice.

      Protein expression analysis

      Strain specific TFR1 expression analysis in homozygous B-hTFR1/hTAU by flow cytometry. Bone marrow and blood cells were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hTFR1/hTAU mice (H/H), and analyzed by flow cytometry with anti-mouse TFR1 antibody (Biolegend, 113808) and anti-human TFR1 antibody (Biolegend, 334108). Mouse TFR1 was detectable in wild-type mice. Human TFR1 was exclusively detectable in homozygous hTFR1/hTAU mice but not in wild-type mice.

      Strain specific TFR1 expression analysis in homozygous B-hTFR1/hTAU by flow cytometry. Bone marrow and blood cells were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hTFR1/hTAU mice (H/H), and analyzed by flow cytometry with anti-mouse TFR1 antibody (Biolegend, 113808) and anti-human TFR1 antibody (Biolegend, 334108). Mouse TFR1 was detectable in wild-type mice. Human TFR1 was exclusively detectable in homozygous hTFR1/hTAU mice but not in wild-type mice.